Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positive Effect of Lecithin-based Delivery Form of Curcuma and Boswellia Extracts on Post-acute COVID-19 Irritable Bowel Syndrome. Two Cohorts of an Open-label Study.

NCT06423586 is registered in ClinicalTrials.gov with Azienda di Servizi alla Persona di Pavia as lead sponsor.

NCT NCT06423586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06423586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positive Effect of Lecithin-based Delivery Form of Curcuma and Boswellia Extracts on Post-acute COVID-19 Irritable Bowel Syndrome. Two Cohorts of an Open-label Study.
Lead sponsor
Azienda di Servizi alla Persona di Pavia
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2021
Completion date
June 10, 2022
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain, dysbiosis, irritable bowel syndrome, post-acute covid-19 syndrome